Pneumonia after Lokivetmab (Cytopoint) in dogs

24 reports to the FDA describe pneumonia in dogs given Lokivetmab. That is 0.4% of all reports for this medicine, compared with 0.1% across reports for all dog medicines, so it is reported unusually often with this medicine.

24Reports
75%Marked serious
8.3%Recovered
29%Died or euthanised
87 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
4 25%
1–2 days
1 6.3%
3–7 days
2 13%
1–4 weeks
0 0.0%
Over a month
9 56%

How the animals did

Recovered
1 4.2%
Recovered with lasting effects
1 4.2%
Still unwell when reported
14 58%
Died
4 17%
Euthanised
3 13%
Not known
1 4.2%

Problems reported at the same time

10 42%
7 29%
6 25%
Respiratory tract disorder
4 17%

Age of the animals

Under 1 year
1
1–3 years
4
4–7 years
7
8–11 years
6
12+ years
6

About this medicine

Lokivetmab controls allergic itch for 4–8 weeks per injection.

Products with this ingredient include Cytopoint. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Lokivetmab cause pneumonia in dogs?
24 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 87 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Pneumonia with similar medicines

All reported side effects of Lokivetmab in dogs · Medicines most reported with pneumonia